Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Parkinson's Disease

  Free Subscription


1 BMC Neurol
1 Exp Neurol
1 Int J Neurosci
1 J Biol Chem
1 J Clin Psychopharmacol
3 Lancet
6 Mov Disord
1 Nat Med
1 Neurosci Lett
3 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Neurol

  1. NORMAN BP, Lubbe SJ, Tan M, Warren N, et al
    Early Onset Parkinson's Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report.
    BMC Neurol. 2017;17:153.
    PubMed     Text format     Abstract available

    Exp Neurol

  2. JAMES SURMEIER D, Halliday GM, Simuni T
    Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
    Exp Neurol. 2017 Aug 2. pii: S0014-4886(17)30206.
    PubMed     Text format     Abstract available

    Int J Neurosci

  3. DE RISI M, Gennaro GD, Picardi A, Casciato S, et al
    Facial emotion decoding in patients with Parkinson's disease.
    Int J Neurosci. 2017 Aug 10:1-13. doi: 10.1080/00207454.2017.1366475.
    PubMed     Text format     Abstract available

    J Biol Chem

  4. AMIREDDY N, Puttapaka SN, Vinnakota RL, Ravuri HG, et al
    The Unintended Mitochondrial Uncoupling Effects of the FDA Approved Anti-Helminth Drug Nitazoxanide Mitigates Experimental Parkinsonism in Mice.
    J Biol Chem. 2017 Aug 10. pii: jbc.M117.791863. doi: 10.1074/jbc.M117.791863.
    PubMed     Text format     Abstract available

    J Clin Psychopharmacol

  5. JORGENSEN A, Thorleifsson A, Jimenez-Solem E, Werge T, et al
    Severe Parkinsonism and Creatine Kinase Increase After Low-Dose Aripiprazole Treatment in a Patient of African Descent.
    J Clin Psychopharmacol. 2017 Aug 3. doi: 10.1097/JCP.0000000000000750.
    PubMed     Text format    


  6. ATHAUDA D, Maclagan K, Skene SS, Bajwa-Joseph M, et al
    Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Aug 3. pii: S0140-6736(17)31585.
    PubMed     Text format     Abstract available

  7. POEWE W, Seppi K
    Insulin signalling: new target for Parkinson's treatments?
    Lancet. 2017 Aug 3. pii: S0140-6736(17)32101.
    PubMed     Text format    

    Parkinson's disease: a complex disease revisited.
    Lancet. 2017;390:430.
    PubMed     Text format    

    Mov Disord

  9. GARCIA-SANZ P, Orgaz L, Bueno-Gil G, Espadas I, et al
    N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
    Mov Disord. 2017 Aug 5. doi: 10.1002/mds.27119.
    PubMed     Text format     Abstract available

  10. BANDRES-CIGA S, Cookson MR
    Alpha-synuclein triggers T-cell response. Is Parkinson's disease an autoimmune disorder?
    Mov Disord. 2017 Aug 7. doi: 10.1002/mds.27116.
    PubMed     Text format    

  11. MIYAUE N, Tada S, Ando R, Yabe H, et al
    cascade stomach associated with delayed-on or no-on phenomenon in a patient with Parkinson's disease.
    Mov Disord. 2017 Aug 7. doi: 10.1002/mds.27109.
    PubMed     Text format    

  12. ROCCA WA
    The future burden of Parkinson's disease.
    Mov Disord. 2017 Aug 7. doi: 10.1002/mds.27114.
    PubMed     Text format    

    Where we've gone "right" in the Parkinson's community.
    Mov Disord. 2017 Aug 11. doi: 10.1002/mds.27076.
    PubMed     Text format    

  14. CHAUDHURI KR, Jenner P
    Two hundred years since James Parkinson's essay on the shaking palsy-Have we made progress? Insights from the James Parkinson's 200 years course held in London, March 2017.
    Mov Disord. 2017 Aug 11. doi: 10.1002/mds.27104.
    PubMed     Text format    

    Nat Med

  15. WONG YC, Krainc D
    alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.
    Nat Med. 2017;23:1-13.
    PubMed     Text format     Abstract available

    Neurosci Lett

  16. FANG J, Chen H, Cao Z, Jiang Y, et al
    Impaired Brain Network Architecture in Newly Diagnosed Parkinson's Disease Based on Graph Theoretical Analysis.
    Neurosci Lett. 2017 Aug 5. pii: S0304-3940(17)30638.
    PubMed     Text format     Abstract available

    PLoS One

  17. LOPEZ A, Ortiz F, Doerrier C, Venegas C, et al
    Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    PLoS One. 2017;12:e0183090.
    PubMed     Text format     Abstract available

  18. ERDOGDU SAKAR B, Serbes G, Sakar CO
    Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease.
    PLoS One. 2017;12:e0182428.
    PubMed     Text format     Abstract available

  19. KIM HW, Oh M, Oh JS, Oh SJ, et al
    Striatofrontal Deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET.
    PLoS One. 2017;12:e0169928.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.